Literature DB >> 16988845

[Radial optic neurotomy: efficacy monitoring using venous ophthalmodynamometry].

M Rauber1, S Müller, U Mester.   

Abstract

BACKGROUND: Retinal central venous outflow pressure (VOP) can be measured with a new ophthalmodynamometer (Meditron, Völklingen, Germany). Radial optic neurotomy (RON) is a new surgical approach for central retinal vein occlusion (CRVO) which is still controversially discussed. Particularly the early formation of retinochoroidal collaterals is intended to achieve normalization of the preoperatively increased pressure in the central retinal vein. We investigated the VOP after RON. PATIENTS AND METHODS: In total, 21 eyes of 21 patients (9 male, 12 female) suffering from CRVO were treated by RON. Pars plana vitrectomy with nasal radial optic neurotomy and peeling of the internal limiting membrane were performed. The mean follow-up time was 10.8 months (6-24 months). Central venous outflow pressure was measured using ophthalmodynamometry.
RESULTS: The most frequent concomitant ophthalmic disease was glaucoma (52%), and the predominantly associated systemic disease was hypertension (81%). After RON in 16 eyes (76%) visual acuity improved by at least 2 lines; in 3 eyes (14%) visual acuity was unchanged (+/-1 line) and in 2 patients (10%) visual acuity decreased by 2 or more lines. Eyes with visual improvement and formation of chorioretinal anastomosis postoperatively showed a significantly lower venous outflow pressure assessed with ophthalmodynamometry.

Entities:  

Mesh:

Year:  2006        PMID: 16988845     DOI: 10.1007/s00347-006-1397-5

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  26 in total

1.  Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.

Authors:  Paul B Greenberg; Adam Martidis; Adam H Rogers; Jay S Duker; Elias Reichel
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases.

Authors:  E M Opremcak; R A Bruce; M D Lomeo; C D Ridenour; A D Letson; A J Rehmar
Journal:  Retina       Date:  2001       Impact factor: 4.256

3.  Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

Authors:  Philip J Rosenfeld; Anne E Fung; Carmen A Puliafito
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2005 Jul-Aug

4.  Pathogenesis of occlusion of the central retinal vessels.

Authors:  S S Hayreh
Journal:  Am J Ophthalmol       Date:  1971-11       Impact factor: 5.258

5.  Characteristics of visual field defects by scanning laser ophthalmoscope microperimetry after radial optic neurotomy for central retinal vein occlusion.

Authors:  Ulrike Schneider; Werner Inhoffen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt
Journal:  Retina       Date:  2005-09       Impact factor: 4.256

6.  Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy.

Authors:  H J Zambarakji; S Ghazi-Nouri; M Schadt; C Bunce; P G Hykin; D G Charteris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-17       Impact factor: 3.117

7.  Venous opthalmodynamometry: a noninvasive method for assessment of intracranial pressure.

Authors:  R Firsching; M Schütze; M Motschmann; W Behrens-Baumann
Journal:  J Neurosurg       Date:  2000-07       Impact factor: 5.115

8.  Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases.

Authors:  W R Green; C C Chan; G M Hutchins; J M Terry
Journal:  Retina       Date:  1981       Impact factor: 4.256

9.  Ophthalmodynamometric assessment of the central retinal vein collapse pressure in eyes with retinal vein stasis or occlusion.

Authors:  Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

10.  Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.